c
serrata
royl
synonym
toona
sinensi
juss
roem
local
known
hill
toon
meem
daral
pakistan
plant
belong
mahogani
famili
meliacea
flower
plant
consist
speci
genera
tree
shrub
grow
tropic
subtrop
region
meliacea
britannica
academ
c
serrata
hard
bark
serv
fuelwood
use
construct
roof
fenc
utensil
ahmad
et
al
agricultur
purpos
tree
best
intercrop
beanbanana
intercrop
ouma
addit
plant
use
customari
treatment
variou
diseas
diabet
mellitu
jan
et
al
hamayun
yaseen
et
al
awan
et
al
rashid
et
al
diarrhea
jan
et
al
fever
khan
et
al
skin
infect
awan
et
al
moreov
crude
extract
contain
sever
phytochem
mainli
phenol
flavonoid
divers
pharmacolog
properti
rang
cytotox
antiglyc
activ
plant
possess
potenti
explor
number
pharmacolog
activ
result
report
plant
may
normal
valid
enough
consid
plant
mechanist
molecular
level
studi
indepth
studi
comprehens
data
pharmacolog
http
receiv
januari
receiv
revis
form
august
accept
august
report
along
toxic
profil
must
studi
establish
c
serrata
c
serrata
reveal
therapeut
potenti
confirm
sever
studi
howev
review
avail
date
cover
allimport
aspect
c
serrata
plant
review
cover
taxonomi
botan
descript
distribut
convent
use
ethnopharmacolog
phytochem
compon
scientif
proven
pharmacolog
activ
activ
compound
articl
aim
provid
foundat
studi
develop
medicin
agent
plant
relev
inform
botan
descript
ethnomedicin
use
phytochem
pharmacolog
activ
c
serrata
collect
publish
literatur
electron
databas
use
collect
relev
inform
includ
googl
scholar
summon
imam
abdulrahman
bin
faisal
univers
portal
web
scienc
scopu
pubm
scienc
direct
springer
link
key
word
c
serrata
toona
serrata
meliacea
flavonoid
phytochem
activ
constitu
ethanopharmacolog
ethnomedicin
antioxid
antiglyc
antiinfect
antimicrobi
antifung
leishmanicid
antidiabet
search
time
limit
book
handbook
natur
occur
insecticid
toxin
tree
pakistan
herbal
phytochemistri
ethnopharmacolog
along
thesi
phytochem
studi
two
plant
ziziphu
oxyphylla
c
serrata
studi
gather
relev
inform
chemic
structur
drawn
use
chemdraw
pro
softwar
pubchem
databas
use
check
iupac
name
phytochem
report
plant
literatur
search
reveal
synonym
c
serrata
royl
toona
serrata
royal
roem
negi
et
al
toona
sinensi
royal
botan
garden
kew
toon
hill
toon
chauhan
et
al
synonym
mention
eflora
pakistan
wwweflorasorg
author
search
extens
literatur
review
regard
plant
search
criteria
includ
articl
english
languag
mention
word
c
serrata
phytochemistri
c
serrata
ethnobiolog
ethnobotani
along
preclin
clinic
studi
regard
c
serrata
initi
broad
term
search
mention
synonym
extract
comprehens
record
match
mention
name
initi
search
follow
filtrat
relev
data
review
end
literatur
search
found
thirteen
relev
articl
c
serrata
eight
articl
toona
sinensi
four
relev
articl
toona
serrata
royal
roem
two
relev
articl
hill
toon
botan
descript
c
serrata
royl
shown
fig
mediums
tree
reach
diamet
rang
featheri
compound
leav
cm
long
besid
pink
flower
c
serrata
long
droop
bunch
capsul
fruit
cm
long
seed
wing
upper
end
cm
long
bark
rough
thick
tree
pakistan
speci
c
serrata
wide
distribut
pakistan
india
burma
nepal
tree
pakistan
myanmar
indonesia
sri
lanka
duseng
et
al
nevertheless
success
cultiv
foothil
area
murre
swat
azad
kashmir
hazara
tree
pakistan
c
serrata
royl
belong
famili
meliacea
known
mahogani
famili
flower
plant
meliacea
famili
consist
speci
genera
tree
shrub
meliacea
britannica
academ
genu
cedrela
compris
around
speci
genera
perveen
zaib
local
convent
medicin
use
c
serrata
c
serrata
widespread
cultur
use
pakistan
sever
ethnomedicin
survey
studi
conduct
highlight
customari
use
c
serrata
differ
part
c
serrata
use
therapeut
purpos
common
report
use
leav
bark
hamayun
ethnobotan
survey
conduct
kaghan
valley
pakistan
jan
et
al
timber
produc
fuelwood
speci
studi
peopl
pick
randomli
interview
differ
valley
kaghan
ethnobotan
knowledg
evalu
regard
c
serrata
usag
leav
commonli
use
manag
diabet
jan
et
al
fouryear
survey
studi
conduct
pakistan
ask
herbalist
select
inform
local
peopl
swat
kohistan
pakistan
studi
report
use
c
serrata
treatment
diabet
hamayun
similarli
yaseen
et
al
awan
et
al
report
manag
diabet
c
serrata
leav
bark
juic
yaseen
et
al
awan
et
al
anoth
studi
conduct
himalayan
region
azad
jammu
kashmir
pakistan
collect
ethnobotan
data
local
inhabit
regard
knowledg
establish
use
c
serrata
studi
reveal
usag
leav
root
stem
decoct
treatment
diabet
rashid
et
al
ethnobotan
knowledg
antidiarrh
medicin
plant
collect
jan
et
al
khyber
pakhtunkhwa
pakistan
c
serrata
bark
report
use
manag
chronic
infantil
dysenteri
jan
et
al
similarli
peopl
kaghan
valley
pakistan
report
use
c
serrata
bark
leav
treatment
dysenteri
awan
et
al
survey
conduct
tehsil
charbagh
interview
elderli
peopl
rural
area
local
herbal
practition
leav
plant
report
digest
aid
khan
et
al
addit
use
diabet
wood
stem
bark
c
serrata
use
local
peopl
herbalist
pakistan
treatment
roundworm
hamayun
similarli
rashid
et
al
report
use
c
serrata
leav
root
stem
decoct
treatment
intestin
worm
local
peopl
azad
jammu
kashmir
rashid
et
al
pfoze
et
al
conduct
ethnobotan
studi
local
inhabit
interview
regard
plant
root
bark
leav
c
serrata
report
use
treatment
hypertens
pfoze
et
al
pakistan
ethnobotan
survey
studi
conduct
shah
et
al
ask
local
elderli
peopl
report
use
c
serrata
treatment
liver
diseas
jaundic
shah
et
al
besid
review
use
c
serrata
leav
bark
use
cool
antipyret
agent
hamayun
awan
et
al
jan
et
al
bark
leav
also
report
treatment
blood
skin
diseas
awan
et
al
interestingli
studi
report
peopl
believ
whole
plant
toxic
haq
use
therapeut
purpos
c
serrata
hard
bark
also
serv
fuelwood
use
construct
roof
fenc
utensil
ahmad
et
al
agricultur
purpos
tree
best
intercrop
beanbanana
intercrop
ouma
summari
customari
therapeut
use
report
c
serrata
present
tabl
therapeut
activ
phytochem
present
c
serrata
main
activ
chemic
compound
c
serrata
flavonoid
glycosid
found
predominantli
leav
plant
ahmad
et
al
flavonoid
isol
identifi
first
time
ahmad
et
al
compound
isol
ethyl
acet
fraction
crude
methanol
leav
extract
identifi
flavonoid
glycosid
hyperosid
quercitrin
astragalin
structur
present
fig
flavonoid
exert
antioxid
antiglyc
activ
among
isol
compound
show
greater
vitro
antioxid
activ
compar
confirm
superior
quercetin
glycosid
kaempferol
glycosid
term
antioxid
potenti
besid
compound
show
better
antioxid
activ
mixtur
pure
compound
suggest
synergist
effect
flavonoid
unlik
antioxid
activ
flavonoid
mixtur
mixtur
exhibit
synergist
antiglyc
effect
ahmad
et
al
c
serrata
contain
high
level
phenol
compound
especi
bark
ahmad
et
al
phenol
compound
exert
mani
pharmacolog
activ
antioxid
antiag
cytotox
antiatherosclerosi
antiinflammatori
tandon
sand
test
c
serrata
leav
extract
phenol
content
phenol
acid
present
leav
extract
ferul
acid
caffeic
acid
ocoumar
acid
vanil
acid
chlorogen
acid
phydroxybenzo
acid
protocatechu
acid
syring
acid
gallic
acid
tandon
sand
structur
present
fig
mani
phytochem
present
c
serrata
mani
exert
pharmacolog
activ
sever
ethnomedicin
survey
studi
report
classic
use
plant
includ
antidiabet
cool
agent
jan
et
al
fever
nerv
tonic
digest
agent
khan
et
al
roundworm
hamayun
chronic
infantil
dysenteri
ulcer
antiperiod
astring
jan
et
al
blood
skin
diseas
awan
et
al
joint
disloc
hypertens
pfoze
et
al
jaundic
liver
diseas
shah
et
al
intestin
worm
diabet
rashid
et
al
part
review
discuss
pharmacolog
studi
report
c
serrata
extract
activ
phytochem
along
ethnopharmacolog
relev
antimicrobi
antivir
antifung
activ
c
serrata
proven
sever
studi
antibacteri
activ
ahmad
et
al
use
agar
well
diffus
method
test
methanol
extract
c
serrata
leav
bark
methanol
fraction
bark
extract
exert
invitro
antimicrobi
action
gramposit
organ
staphylococcu
aureu
proteu
mirabili
bacillu
subtili
gramneg
organ
escherichia
coli
citrobact
spp
salmonella
typhi
bark
extract
show
signific
inhibit
citrobact
spp
growth
inhibit
zone
mm
concentr
suggest
c
serrata
antimicrobi
activ
due
high
content
phenol
present
bark
ahmad
et
al
anoth
studi
conduct
jan
et
al
evalu
antibacteri
effect
c
serrata
crude
extract
variou
concentr
mgml
use
agar
well
diffus
method
crude
extract
c
serrata
show
invitro
inhibitori
potenti
toward
microb
pseudomona
aeruginosa
salmonella
typhi
escherichia
coli
proteu
vulgari
staphylococcu
aureu
zone
inhibit
measur
differ
concentr
c
serrata
crude
extract
minimum
inhibitori
concentr
mic
c
serrata
ethanol
fraction
mgml
p
aeruginosa
mgml
e
coli
typhi
aureu
p
vulgari
accord
jan
et
al
antimicrobi
activ
might
contribut
presenc
tannin
steroid
volatil
oil
presenc
phenol
compound
jan
et
al
bibi
et
al
report
c
serrata
methanol
leav
extract
invitro
antimicrobi
activ
mgml
staphylococcu
epidermidi
pseudomona
spp
maximum
zone
inhibit
mm
minimum
inhibit
escherichia
coli
growth
howev
show
moder
inhibit
staphylococcu
aureu
kelbsiella
pneumonia
bibi
et
al
aureu
typhi
e
coli
flexneri
chief
infecti
agent
caus
diarrhea
human
ann
gebo
use
c
serrata
variou
herbal
remedi
treatment
diarrhea
report
differ
commun
especi
pakistan
jan
et
al
c
serrata
show
potent
antimicrobi
activ
variou
strain
bacteria
caus
diarrhea
activ
may
support
commun
use
antidiarrh
agent
addit
c
serrata
exhibit
antivir
activ
lifethreaten
viru
ie
sever
acut
respiratori
syndrom
coronaviru
sarscov
crude
tender
leaf
extract
exert
vitro
inhibit
sarscov
replic
ec
valu
chen
et
al
although
activ
extract
exhibit
consid
signific
old
method
use
establish
antibacteri
activ
plant
extract
sophist
reliabl
method
ie
dilut
method
use
spectrophotomet
avail
speci
studi
report
gener
util
author
possibl
due
sensit
even
low
dose
herb
herbal
extract
besid
dose
appli
claim
signific
result
ie
mgml
high
consid
potent
antibacteri
extract
plant
part
must
possess
activ
low
concentr
especi
emerg
strain
bacteria
world
endang
pose
resist
phenomenon
statist
tool
use
studi
improp
proper
anova
ttest
base
data
evalu
analysi
report
make
data
reliabl
signific
ic
observ
none
studi
mic
mec
valu
report
prime
import
human
clinic
use
presenc
phenol
compound
well
tannin
mention
sourc
antimicrobi
properti
henc
studi
ultim
need
confirm
natur
structur
specif
phenol
compound
tannin
mention
properti
studi
confirm
activ
impart
phenol
flavonoid
class
chemic
entiti
compound
may
explor
clinic
trial
produc
drug
uniqu
properti
term
treatment
concentr
mic
valu
extract
dose
appli
seem
quit
high
may
result
toxic
effect
therapeut
intervent
similarli
effect
evalu
strain
microb
wide
studi
almost
form
antimicrobi
research
henc
investig
multidrug
resist
well
emerg
strain
need
possibl
exist
plant
phytochem
may
exhibit
cytotox
effect
variou
tissu
lack
antimicrobi
effect
given
concentr
probabl
use
may
limit
mutat
genet
modifi
microbi
strain
henc
indepth
studi
need
correl
invitro
invivo
toxic
data
develop
report
model
allow
predict
system
toxic
largescal
clinic
trial
addit
activ
gramposit
gramneg
bacteria
c
serrata
show
inhibitori
activ
strain
fungi
use
standard
agar
dilut
method
bibi
et
al
report
invitro
antifung
activ
c
serrata
extract
fusarium
oxysporum
mgml
chloroform
fraction
c
serrata
extract
show
inhibit
f
oxysporum
growth
wherea
methanol
fraction
show
inhibit
bibi
et
al
methanol
fraction
c
serrata
bark
extract
show
signific
invitro
antifung
activ
candida
albican
ic
valu
wherea
chloroform
fraction
leav
extract
show
signific
activ
trichophyton
rubrum
ic
valu
ml
ahmad
et
al
c
albican
report
robert
et
al
attribut
diarrhea
caus
certain
antimicrobi
medic
robert
et
al
antifung
activ
strain
fungi
may
support
customari
use
c
serrata
treatment
diarrhea
jan
et
al
support
data
particular
group
peopl
suffcient
evid
use
plant
extract
fungal
infect
antifung
studi
seem
preliminari
data
sure
gap
research
exist
term
evalu
effect
extract
resist
well
commonli
prevail
strain
take
research
till
mechanist
level
advers
effect
may
report
worriyng
factor
dose
mention
may
potenti
toxic
high
concentr
ie
use
human
treatmnet
thu
critic
develop
advanc
model
antifung
potenti
includ
resist
strain
low
dose
proper
standard
well
statist
model
compar
data
overal
antibacteri
antifung
studi
report
exhibit
weak
approach
appli
proper
pharmacolg
model
consist
vivo
cell
cultur
studi
utmost
need
order
confirm
potenti
toxic
therput
activ
plant
extract
data
present
may
reproduc
need
indepth
research
mic
valu
observ
dose
appli
model
studi
use
contol
appli
studi
permit
claim
data
clinic
use
author
suggest
explor
activ
use
vivo
model
low
dose
toxic
report
reproduc
properli
valid
leishmaniasi
parasit
infecti
diseas
affect
million
peopl
around
world
takahashi
et
al
symptom
rang
subclin
local
skin
lesion
dissemin
infect
affect
mucou
membran
viscera
murray
et
al
formal
cedrela
spp
use
treatment
leishmania
ulcer
skin
diseas
za
et
al
c
serrata
along
plant
myanmar
timber
extract
examin
takahashi
et
al
activ
leishmania
promastigot
c
serrata
timber
extract
show
potent
vitro
leishmanicid
activ
mic
valu
mlc
takahashi
et
al
anoth
studi
evalu
c
serrata
leishmanicid
activ
ahmad
al
show
signific
activ
chloroform
fraction
bark
extract
ic
valu
ahmad
et
al
besid
antiparasit
activ
leishmania
spp
c
serrata
exert
potent
antiparasit
activ
speci
parasit
includ
trypanosoma
spp
nhexan
fraction
leav
extract
show
potent
invitro
activ
brucei
ic
valu
wherea
chloroform
fraction
bark
extract
show
even
potent
activ
cruzi
ic
valu
nhexan
fraction
leav
extract
exhibit
similar
activ
cruzi
ic
valu
ahmad
et
al
activ
parasit
interest
signific
howev
valu
extract
real
practic
parasit
need
explor
mostli
result
vari
great
extent
model
treatment
chang
dose
concentr
may
easili
appli
clinic
trial
especi
patient
leishmani
diseas
howev
risktobenefit
ratio
extract
term
side
effect
advers
effect
dose
therapeut
outcom
import
make
plant
use
respect
speci
market
worthi
add
leishmani
diseas
import
field
scope
research
number
laboratori
research
util
everi
possibl
resourc
find
signific
potent
agent
erad
leishmani
diseas
despit
much
work
need
properli
appli
plant
current
diseas
basic
hindranc
use
plant
part
ie
extract
treat
toxic
solvent
nhexan
chloroform
may
conisd
serious
time
solvent
resdiu
may
play
cytotox
antiparasit
role
may
overrul
first
literatur
report
suggest
low
dose
chloroform
suffici
enough
death
henc
microb
parasit
may
kill
compr
low
dose
likewis
none
studi
report
phytochem
class
plant
respons
activ
probabl
may
synergist
effcet
exert
leav
bark
extract
plant
respons
activ
none
posit
especi
neg
control
observ
studi
order
assur
effect
due
extract
potenti
rather
solvent
case
even
factor
overul
still
studi
need
appli
din
proper
pharmcolog
model
cell
cultur
techniqu
vivo
model
toxic
profil
extract
minimum
dose
select
key
import
appli
model
clincial
studi
overcom
research
essenti
term
isol
activ
chemic
entiti
structur
elucid
clinic
trial
level
multicent
mutlifacet
studi
model
use
activ
proper
standard
posit
neg
underli
mechan
effect
safe
dose
cytochrom
enzym
util
metabol
importantli
interact
drug
need
defin
one
hypothes
suggest
hyperglycemiainduc
vascular
patholog
diabet
end
complic
increas
level
advanc
glycat
product
age
suggest
age
produc
case
intracellular
hyperglycemia
trigger
intracellular
autooxid
glucos
variou
reactiv
product
react
intracellular
extracellular
protein
form
age
brownle
diabet
patient
protect
glycationderiv
free
radic
damag
use
antioxid
compound
combin
antiglyc
antioxid
activ
report
effect
antidiabet
agent
c
serrata
bark
extract
extract
differ
concentr
show
highest
vitro
activ
age
format
ic
valu
mgml
similarli
leav
extract
show
signific
vitro
antiglyc
activ
ic
valu
mgml
c
serrata
contain
highest
content
phenol
flavonoid
bark
leav
respect
plant
antiglyc
activ
may
attribut
presenc
compound
ahmad
et
al
addit
ethyl
acet
fraction
c
serrata
leav
extract
show
signific
vitro
antiglyc
activ
ic
valu
mgml
extract
prepar
dissolv
mg
ml
stock
solut
three
dilut
prepar
concentr
stock
solut
ahmad
et
al
antioxid
antiglyc
activ
c
serrata
could
use
prevent
diabet
complic
diabet
patient
mention
sever
ethnobotan
studi
report
cultur
use
c
serrata
pakistan
treatment
manag
diabet
yaseen
et
al
hamayun
jan
et
al
awan
et
al
mention
pharmacolog
studi
support
use
presenc
phenol
flavonoid
may
inde
impart
antioxid
antiglyc
potenti
plant
howev
gener
seem
major
drawback
report
vitro
model
activ
need
updat
advanc
level
extract
dilut
must
test
vivo
preliminari
cell
cultur
techniqu
follow
cell
cultur
studi
model
may
effect
appli
human
clinic
trial
age
emerg
domain
research
ontheway
find
novel
effect
sourc
treat
glyoxal
methylglyox
fructos
amin
adduct
etc
extract
bark
plant
may
play
vital
role
provid
sourc
age
inhibitor
predict
model
mechan
import
elucid
order
success
util
plant
chemic
entiti
age
relat
complic
especi
diabet
patient
plant
extract
may
particularli
studi
hepatotox
potenti
diabet
peopl
may
comorbid
plant
extract
may
affect
liver
condit
furthermor
interact
plant
extract
compound
may
lack
effect
convent
drug
use
treat
diabet
age
relat
complic
success
isol
activ
chemic
may
interest
help
health
commun
research
combat
diseas
concern
level
diseas
report
provid
preliminari
without
proper
evid
model
use
preliminari
mechan
particularli
lack
vivo
data
likewis
toxic
studi
cell
cultur
relat
studi
avail
report
may
confirm
plant
extract
risk
advers
effect
high
dose
besid
expand
studi
shape
clinic
trial
intens
need
treat
effect
emerg
preval
diseas
age
respect
antioxid
activ
number
question
exist
gener
plant
extract
possess
antioxid
activ
due
commonli
occur
flavonoid
phenol
compound
first
presenc
antioxid
potenti
guarante
valid
authent
activ
alway
especi
studi
protocol
involv
mere
competit
bleach
probe
crocin
bleach
assay
orac
assay
reaction
differ
probe
tosc
assay
indirect
method
reduct
oxid
persist
radic
dpph
teac
frap
etc
extens
data
avail
research
claim
antioxid
potenti
base
aforement
protocol
fact
model
reproduc
pharmacolog
appli
vivo
human
model
current
studi
one
exampl
interest
see
antioxid
antiglyc
potenti
plant
howev
data
level
preliminari
conclus
debat
regard
antioxid
potenti
alway
exist
everi
plant
extract
phenol
flavonoid
moieti
impart
antioxid
potenti
plant
appli
practic
work
need
especi
cellbas
antioxid
assay
antioxid
potenti
plant
extract
prove
alongwith
toxic
cytotox
toward
cell
secondli
molecular
mechan
extract
need
establish
henc
activ
isol
novel
flavonoid
phenol
plant
prime
import
studi
report
even
role
mortal
commonli
use
antioxid
beta
caroten
vitamin
c
e
thu
care
requir
order
overload
immun
system
contain
common
antioxid
food
veget
sourc
antioxid
plant
extract
may
lead
un
toward
consequ
addit
clinic
studi
requir
look
effect
commonli
occur
antioxid
alon
combin
antioxid
claim
plant
extract
issu
prime
import
establish
posit
neg
role
antioxid
pharmacolog
biolog
reproduc
model
view
current
research
antioxid
author
suggest
conduct
synergist
studi
extract
plant
commonli
found
antioxid
food
drink
veget
present
clear
pictur
use
antioxid
treatment
diseas
overal
use
potenti
antioxid
debat
need
care
attent
excess
amount
may
lead
seriou
consequ
includ
death
increas
mortal
ratio
author
suggest
proper
biolog
cell
cultur
studi
sound
posit
neg
control
well
synergist
studi
commonli
occur
antioxid
addit
durat
frequenc
antioxid
usag
may
also
consid
prioriti
basi
case
peopl
patient
use
veget
fruit
alongwith
drink
contain
alreadi
high
amount
antioxid
insecticid
potenti
plant
test
ahmad
et
al
methanol
extract
plant
appli
red
flour
beetl
ie
tribolium
castaneum
reveal
toxic
ahmad
et
al
contrast
perveen
khan
studi
effect
variou
polar
solvent
mention
insect
ld
valu
methanol
nbutanol
ethyl
acet
aqueou
fraction
observ
plant
studi
confirm
posit
effect
plant
speci
insect
howev
genera
insect
diversifi
complex
genet
makeup
possibl
exist
insecticid
effect
may
mediat
via
plant
metabolit
rather
plant
current
data
advoc
littl
scientif
knowledg
may
appli
practic
addit
lack
bulk
plant
materi
insuffici
support
govern
due
less
avail
toxic
data
may
pose
difficulti
plant
use
ideal
insecticid
drug
variou
studi
regard
formul
requir
address
sustain
effect
qualiti
stabil
c
serrata
besid
dose
unit
use
confus
terminolog
common
comprehens
may
appli
order
assess
potenti
plant
extract
compar
previou
report
insecticid
activ
studi
report
reflect
model
pharmacolog
reproduc
applic
vivo
clinic
studi
natur
genet
makeup
insect
human
vari
huge
extent
addit
inform
clearli
provid
durat
dose
use
extract
though
activ
provid
preliminari
inform
regard
insecticid
activ
toxic
still
advanc
studi
use
cell
cultur
vivo
toxic
studi
anim
model
proper
control
dose
durat
extract
need
test
establish
toxic
plant
vitro
cytotox
studi
support
plant
antiprolif
activ
variou
cell
line
suggest
preliminari
potenti
treatment
variou
type
cancer
includ
lung
prostat
ovarian
leukemia
etc
c
serrata
leav
bark
extract
show
signific
cytotox
activ
cell
chloroform
fraction
bark
extract
show
signific
invitro
cytotox
activ
cc
valu
similarli
nhexan
fraction
leav
extract
show
signific
cytotox
activ
cc
valu
ahmad
et
al
gallic
acid
phenol
compound
extract
c
serrata
leav
also
shown
vitro
cytotox
activ
prostat
cancer
compound
shown
activ
prostat
cancer
cell
via
differ
mechan
includ
mitochondriamedi
apoptosi
gener
reactiv
oxygen
speci
inhibit
cell
growth
phase
chen
et
al
addit
c
serrata
crude
leav
extract
shown
vitro
cytotox
activ
lung
cancer
crude
leav
extract
induc
activ
proteas
enzym
lead
apoptosi
cell
also
extract
show
antiprolif
activ
interfer
cyclin
cyclin
e
express
chang
et
al
similarli
phenol
compon
c
serrata
leav
show
antiprolif
apoptot
activ
human
premyelocyt
leukemia
cell
phenol
compon
c
serrata
exert
apoptot
activ
cell
variou
mechan
includ
caspas
activ
releas
cytochrom
c
specif
proteolyt
cleavag
parp
also
known
poli
adpribos
polymeras
gener
reactiv
oxygen
speci
h
reduct
level
yang
et
al
kakumu
et
al
addit
vitro
ex
vivo
activ
ovarian
cancer
cell
establish
c
serrata
aqueou
leav
extract
inhibit
growth
cell
phase
establish
vitro
antiprolif
activ
similar
studi
also
establish
c
serrata
vitro
cytotox
activ
oral
squamou
carcinoma
cell
cervic
carcinoma
chia
et
al
zhen
et
al
cytotox
model
provid
clear
inform
first
gap
lack
support
evid
vivo
studi
besid
activ
present
vitro
one
cell
line
ie
breast
cell
line
hela
cell
line
prostat
ovarian
cell
line
etc
may
studi
extract
evalu
potenti
may
promis
role
list
cytotox
drug
limit
inform
cytotox
provid
plant
mean
data
provid
satisfactori
evid
implic
plant
cancer
cancerrel
complic
extens
data
consist
proper
vitro
vivo
model
dose
rang
safeti
mechan
action
relev
target
treat
much
need
mention
previous
first
role
solvent
use
may
sort
herein
solvent
use
fpor
extract
toxic
halogen
solvent
ie
chloroform
halogen
solvent
well
known
toxic
death
even
low
solvent
ratio
furthermor
cytotox
studi
involv
solvent
data
gener
better
perform
activ
use
dmso
allow
specifi
concentr
importantli
molecular
mechan
need
elabor
seri
cell
line
may
studi
variou
dose
level
involv
lowest
highest
dose
concentr
proper
pharmacolog
toxicolog
guidelin
avail
toxic
potenti
studi
vitro
experi
first
follow
vitro
experi
extract
studi
anim
toxic
model
use
histolog
immunohistochemistri
studi
henc
plant
need
much
attent
aspect
data
may
justifi
cytotox
henc
use
agent
treatment
cancer
preliminari
cell
cultur
studi
may
decid
track
plant
extract
whether
util
studi
anticanc
studi
simpl
cytotox
potenti
may
suffici
put
plant
list
cancer
treatment
drug
although
plant
demonstr
promis
vitro
activ
c
serrata
pharmacolog
activ
test
anim
model
human
plant
find
extens
custom
use
diabet
hypertens
well
liver
diseas
dysenteri
moreov
studi
support
pharmacolog
activ
perform
variou
part
plant
differ
solvent
studi
establish
preliminari
role
c
serrata
antioxid
liver
diseas
antimicrobi
dysenteri
inhibitor
advanc
glycat
product
ie
glyoxal
methylglyox
fructos
amin
adduct
diabet
although
potenti
role
may
assum
plant
stage
activ
lack
major
gap
applic
human
system
gap
includ
lack
data
show
confirm
pharmacolog
activ
human
subject
ie
volunt
patient
model
unavail
mechanist
studi
pharmacolog
activ
absenc
v
studi
micro
dose
therapeuticsubtherapeut
dose
well
toxic
advers
effect
associ
plant
use
may
conclud
proper
posit
neg
control
alongwith
durat
dose
extract
appli
requir
especi
case
antioxid
assay
discuss
detail
previous
moreov
activ
moieti
isol
report
mostli
report
compound
none
novel
hit
lead
compound
report
far
plant
addit
alreadi
isol
compound
studi
toxic
clinic
studi
make
proper
dosag
form
drug
plant
market
avail
end
user
vivo
pharmacolog
studi
clinic
trial
held
c
serrata
till
date
wwwclinicaltrialsorg
correspondingli
report
clinic
trial
c
serrata
part
extract
isol
known
compound
even
secondari
metabolit
isol
report
may
explor
pharmacokinet
pharmacodynam
properti
well
side
effect
toxic
clinic
trial
may
convert
potenti
market
drug
moieti
opportun
numer
pharmacolog
activ
antiinflammatori
analges
diuret
cardiovascular
skin
infect
liver
jaundic
renal
problem
digest
disord
mental
diseas
still
exist
plant
may
good
chanc
research
appli
plant
extract
mention
activ
well
report
toxic
profil
plant
anim
model
current
limit
studi
report
biolog
effect
detail
studi
toxic
side
effect
variou
dose
well
longterm
use
highli
need
address
underli
mechan
abort
inflamm
analgesia
cv
relat
disord
plethora
evid
hepat
toxic
associ
use
convent
crude
drug
report
due
perturb
immun
system
vital
interest
investig
possibl
acut
andor
chronic
liver
damag
follow
ingest
plant
extract
contain
alkaloid
flavonoid
natur
herbal
extract
reason
antiinflammatori
cv
analges
therapeut
effect
plant
may
studi
chronic
hepat
cholestasi
druginduc
autoimmun
vascular
lesion
hepat
fibrosi
anim
model
besid
lack
evid
exist
c
serrata
extract
interact
cytochrom
enzym
ie
case
compound
extract
bind
coval
enzym
possibl
may
exist
wherebi
tcell
activ
cytokin
may
releas
thu
lead
toward
complic
immun
respons
foremost
import
phenomenon
observ
effect
convent
drug
avail
mention
pharmacolog
activ
diseas
nsaid
antihypertens
diuret
etc
synergist
antagonist
effect
drug
use
concomitantli
c
serrata
extract
phytochem
prime
import
achiev
success
pharmaceut
care
model
henc
clinic
trial
multicent
multifacet
popul
key
import
therapeut
potenti
plant
isol
compound
consid
worthi
absenc
toxic
fatal
advers
effect
toxic
studi
prime
import
herbal
product
isol
compound
particular
although
sever
pharmacolog
activ
report
c
serrata
support
widespread
histor
use
plant
diabet
dysenteri
hypertens
liver
diseas
none
author
carri
toxicolog
investig
one
studi
ahmad
et
al
perform
cytotox
studi
plant
show
cytotox
yet
vitro
studi
besid
major
studi
found
may
report
toxic
indepth
focu
need
term
toxic
studi
vivo
system
well
cell
cultur
studi
includ
exposur
herbal
extract
isol
drug
variou
dose
concentr
ie
minimum
maximum
highest
dose
may
properli
studi
vivo
anim
model
follow
expand
studi
cell
cultur
human
subject
thereof
importantli
oral
toxic
may
determin
safe
use
plant
relat
part
drug
still
exist
gap
studi
topic
vivo
toxic
profil
c
serrata
assess
riskbenefit
profil
plant
prior
clinic
applic
toxic
studi
limit
insuffici
support
safeti
efficaci
plant
extract
fraction
variou
diseas
may
delay
use
therapeut
purpos
likewis
avail
literatur
lack
scientif
knowledg
toxic
plant
activ
constitu
herbdrug
interact
extract
interact
pharmaceut
drug
need
investig
systemat
level
ie
metabol
cytochrom
liver
enzym
system
well
proteas
inhibitor
worthi
mention
pharmacokinet
absorpt
distribut
metabol
elimin
pharmacodynam
studi
plant
extract
yet
investig
larg
clinic
trial
translat
therapeut
purpos
futur
prospect
potenti
util
observ
first
instanc
plant
widespread
use
antidiabet
antihypertens
antimicrobi
liver
diseas
similarli
compound
isol
test
respect
diseas
wherebi
show
basic
mechan
antioxid
free
radic
entrapp
cytotox
bacteriostaticbactericid
glycat
product
diabet
mechan
studi
far
includ
tradit
basic
level
protocol
involv
mere
competit
bleach
probe
crocin
bleach
assay
orac
assay
reaction
differ
probe
tosc
assay
indirect
method
reduct
oxid
persist
radic
dpph
teac
frap
etc
advanc
level
reproduc
valid
result
cellbas
antioxid
assay
much
need
resolv
phenomenon
antioxid
potenti
plant
c
serrata
enorm
potenti
work
area
interest
research
may
includ
isol
lead
compound
well
compound
due
current
plant
potenti
respect
treatment
diseas
number
commun
specif
compound
establish
role
antidiabet
antihypertens
well
use
liver
diseas
pharmacolog
activ
mechanist
potenti
order
explor
proper
mechan
extract
pure
compound
treatment
diabet
hypertens
liver
diseas
toxic
determin
herbal
extract
isol
compound
differ
preclin
clinic
vivo
system
clinic
trial
herbal
product
isol
compound
variou
stage
includ
v
well
translat
preclin
data
clinic
studi
final
convers
suitabl
dosag
form
order
use
common
popul
plant
potenti
studi
mayb
interest
speci
attract
research
futur
studi
author
support
presenc
mani
pharmacolog
activ
base
phenol
flavonoid
compound
present
plant
case
phenol
flavonoid
compound
report
vitro
antioxid
antibacteri
antidiabet
potenti
mandatori
confirm
sourc
natur
compound
concern
structur
c
serrata
plant
compound
mention
activ
may
previous
report
speci
well
advanc
studi
may
possibl
conduct
research
decid
regard
ethnopharmacolog
phytochem
relev
well
import
plant
compound
may
isol
report
wherea
case
novel
compound
indepth
molecular
targetbas
studi
urgent
need
produc
new
drug
health
relat
purpos
number
studi
whether
pharmacolog
toxic
safeti
studi
preclin
clinic
studi
amount
data
avail
plant
may
suffici
enough
favor
plant
proper
therapeut
medicin
herb
pharmacolog
activ
report
plant
mostli
base
preliminari
assess
model
use
lack
proper
standard
use
dose
appli
discret
data
found
plant
regard
extract
dose
natur
extract
model
anim
use
standard
drug
statist
analysi
appli
normal
evalu
data
per
guidelin
well
obtain
signific
reliabl
result
anim
model
plant
extract
properli
standard
term
activ
principl
compar
dose
standard
well
control
drug
use
appropri
statist
method
valid
data
along
clinic
trial
major
recommend
plant
explor
c
serrata
royl
one
famou
plant
pakistan
india
mani
ethnobotan
studi
report
cultur
use
plant
south
asian
commun
common
customari
use
report
c
serrata
treatment
diabet
digest
disord
eg
diarrhea
dysenteri
parasit
worm
fever
toxic
c
serrata
report
ethnomedicin
survey
yet
toxic
case
report
compound
isol
c
serrata
ethyl
acet
methanol
extract
quantit
phytochem
analysi
studi
conduct
explor
plant
activ
phytochem
howev
flavonoid
phenol
compound
got
sever
research
attent
flavonoid
predominantli
exist
c
serrata
leav
wherea
phenol
predominantli
exist
bark
two
class
flavonoid
identifi
quercetin
kaempferol
glycosid
moreov
eight
phenol
acid
compound
identifi
eg
ferrul
acid
caffeic
acid
ocoumar
acid
etc
mani
studi
avail
demonstr
compound
vitro
antioxid
activ
bioactiv
phytochem
class
identifi
qualit
phytochem
analysi
studi
includ
alkaloid
flavonoid
terpenoid
saponin
tannin
cardiac
glycosid
steroid
articl
explain
convent
use
c
serrata
support
modern
pharmacolog
studi
commonli
report
use
eg
treatment
diabet
support
vitro
antiglyc
antioxid
activ
prevent
diabet
vascular
complic
use
diarrhea
support
antibacteri
antifung
activ
variou
strain
associ
infecti
diarrhea
use
histor
treatment
leishmania
ulcer
well
use
support
activ
l
promastigot
wherea
use
treatment
liver
diseas
support
vitro
antioxid
activ
oxid
stress
highli
associ
propag
initi
liver
diseas
eg
alcohol
nonalcohol
liver
diseas
major
area
research
conduct
c
serrata
vitro
antioxid
antiinfect
activ
activ
evalu
variou
test
phenol
flavonoid
content
mostli
attribut
activ
antiglyc
activ
got
research
attent
well
c
serrata
bark
extract
show
strongest
inhibit
age
format
suggest
c
serrata
phenol
content
attribut
activ
well
c
serrata
vitro
cytotox
activ
area
interest
mani
research
activ
establish
variou
type
cell
line
articl
aim
provid
good
insight
review
understand
c
serrata
potenti
studi
explor
depth
plant
show
therapeut
potenti
modern
invitro
studi
henc
vivo
advanc
studi
pharmacolog
reproduc
valid
model
consist
proper
dose
durat
frequenc
extract
appli
control
use
studi
molecular
mechan
need
enrout
plant
toward
isol
activ
chemic
establish
pharmacolog
activ
clinic
trial
import
hot
area
research
nowaday
herbdrug
interact
peopl
prefer
use
natur
product
ie
herb
use
convent
drug
remain
possibl
interact
whether
may
induct
inhibit
howev
effect
need
explor
plant
extract
claim
possess
pharmacolog
activ
particular
drug
pharmacolog
class
may
appli
studi
cytochrom
system
effect
limit
inform
avail
regard
plant
review
short
abstract
inform
report
activ
toxic
phytochem
report
plant
author
believ
data
regard
plant
suffici
produc
comprehens
review
howev
current
minireview
c
serrata
highlight
report
data
gap
research
exist
plant
classifi
valuabl
ethnopharmacolog
medicin
plant
articl
summar
botan
descript
ethnopharmacolog
use
activ
phytochem
pharmacolog
activ
c
serrata
plant
show
interest
therapeut
potenti
howev
unfortun
pharmacolog
studi
conduct
carri
invitro
date
none
preclin
clinic
studi
perform
confirm
activ
similarli
quantit
phytochem
studi
done
isol
monomolecular
phytochem
compound
plant
reveal
therapeut
potenti
cytotox
agent
variou
cell
line
studi
must
conduct
evalu
c
serrata
cytotox
activ
vivo
studi
clinic
trial
prove
role
anticanc
agent
futur
toxic
got
attent
lack
toxicolog
studi
conduct
plant
wit
articl
articl
evidenc
huge
gap
research
done
c
serrata
futur
invivo
studi
must
carri
explor
activ
indepth
anim
valid
invitro
activ
addit
clinic
trial
must
held
evalu
c
serrata
safeti
clinic
efficaci
human
rizwan
ahmad
correspondingauthor
conceiv
idea
provid
guidanc
resourc
review
articl
structur
articl
per
journal
guidelin
hanin
almubayedh
wrote
articl
design
graphic
abstract
drew
chemic
structur
use
chemdraw
pro
softwar
cite
refer
per
jep
guidelin
research
receiv
specif
grant
fund
agenc
public
commerci
notforprofit
sector
conflict
interest
author
